Inflammatory Bowel Disease Linked to Prostate Cancer
Drug Improves Survival in Metastatic Breast Cancer
New Biotech Technique Accelerates Protein Therapy Research
Huntington’s Disease Provides New Cancer Weapon
Patients with Huntington’s disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population. Northwestern Medicine scientists have discovered why Huntington’s is so toxic to cancer cells and harnessed it for a novel approach to treat cancer, a new study…
Suicide Molecules Kill Any Cancer Cell
New Insights into Herpes Virus Could Inform Vaccine Development
Nanomedicine Opens Door to Precision Medicine for Brain Tumors
New Cancer Drug as Potential Food Allergy Treatment?
Preclinical Study: Treatment Candidate Crosses Blood-Brain Barrier to Reach Tumors
Evaluating a Therapy for Rare Midgut Tumors
Lurie Cancer Center to Lead Trial for Rare Cancer Patients
New Signaling Pathway Insights Could Lead to Novel Neurological Disorder Therapies
New Antidepressant Target Discovered
CHICAGO — Northwestern Medicine scientists have shown how manipulating a novel target in the brain using gene therapy could lead to new treatments for depression. The investigators showed decreasing a set of proteins called HCN channels reduced depression-like behavior in mice. If replicated in humans, the findings could inform fresh therapies for millions of patients…